Review
doi: 10.1016/s0738-081x(98)00047-9.
Adverse skin reactions to the nicotine transdermal system
Affiliations
- PMID: 9787974
- DOI: 10.1016/s0738-081x(98)00047-9
Item in Clipboard
Review
Adverse skin reactions to the nicotine transdermal system
Clin Dermatol.
1998 Sep-Oct.
No abstract available
Similar articles
-
Allergic contact dermatitis from transdermal nicotine systems.Contact Dermatitis. 1993 Aug;29(2):104-5. doi: 10.1111/j.1600-0536.1993.tb03500.x. Contact Dermatitis. 1993. PMID: 8365171 No abstract available.
-
Contact allergy to nicotine from a nicotine patch.Contact Dermatitis. 1993 Oct;29(4):214-5. doi: 10.1111/j.1600-0536.1993.tb03545.x. Contact Dermatitis. 1993. PMID: 8281791 No abstract available.
-
The nicotine transdermal system.Clin Dermatol. 1998 Sep-Oct;16(5):599-615. doi: 10.1016/s0738-081x(98)00046-7. Clin Dermatol. 1998. PMID: 9787973 Review. No abstract available.
-
[Smoking cessation with the nicotine patch].Z Arztl Fortbild (Jena). 1995 Oct;89(5):505-9. Z Arztl Fortbild (Jena). 1995. PMID: 8578778 Review. German.
-
Reactivity to nicotine patches wrongly blamed on contact allergy.Contact Dermatitis. 1997 Jul;37(1):44-5. doi: 10.1111/j.1600-0536.1997.tb00382.x. Contact Dermatitis. 1997. PMID: 9255494 No abstract available.
Cited by
-
Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.Clin Drug Investig. 2010;30(1):41-9. doi: 10.2165/11531270-000000000-00000. Clin Drug Investig. 2010. PMID: 19995097 Clinical Trial.
-
Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.CNS Neurosci Ther. 2010 Spring;16(1):51-60. doi: 10.1111/j.1755-5949.2009.00119.x. CNS Neurosci Ther. 2010. PMID: 20070789 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
